Recommended Adult Immunization Schedule --- United

States, 2010
Weekly
January 15, 2010 / 5901!"1-#
The Advisory Committee on Immunization Practices (ACIP) annually reviews the recommended
Adult Immunization Schedule to ensure that the schedule reflects current recommendations for
the licensed vaccines. In October !!"# ACIP a$$roved the Adult Immunization Schedule for
!%!# which includes several chan&es. A bivalent human $a$illomavirus vaccine ('P() was
licensed for use in females in October !!". ACIP recommends vaccination of females with
either 'P( or the )uadrivalent human $a$illomavirus vaccine ('P(*). 'P(* was licensed for
use in males in October !!"# and ACIP issued a $ermissive recommendation for use in males.
Introductory sentences were added to the footnotes for measles# mum$s# rubella# influenza#
$neumococcal# he$atitis A# he$atitis +# and menin&ococcal vaccines. Clarifications were made to
the footnotes for measles# mum$s# rubella# influenza# he$atitis A# menin&ococcal# and
'aemo$hilus influenza ty$e b vaccines# and schedule information was added to the he$atitis +
vaccine footnote.
Additional information is available as follows, schedule (in -n&lish and S$anish) at
htt$,..www.cdc.&ov.vaccines.recs.schedules.adult/schedule.htm0 adult vaccination at
htt$,..www.cdc.&ov.vaccines.default.htm0 ACIP statements for s$ecific vaccines at
htt$,..www.cdc.&ov.vaccine.$ubs.aci$/list.htm0 and re$ortin& adverse events at
htt$,..www.vaers.hhs.&ov or by tele$hone# 1!!/1/2"32.
$han%es &or 2010
Footnotes (Figures 1 and 2)
The human papillomavirus (HPV) footnote (#2) includes language that a
bivalent HPV vaccine (HPV2) has been licensed for use in females. Either
HPV2 or the quadrivalent human papillomavirus vaccine (HPV) can be used
for vaccination of females aged !" through 2# $ears. %n addition& language
has been added to indicate that '(%P issued a permissive recommendation
for use of HPV in males.
The measles& mumps& rubella ())*) footnote (#+) has language added to
clarif$ ,hich adults born during or after !"+- do not need ! or more doses of
))* vaccine for the measles and mumps components& and clari.es ,hich
,omen should receive a dose of ))* vaccine. 'lso& interval dosing
information has been added to indicate ,hen a second dose of ))* vaccine
should be administered. /anguage has been added to highlight
recommendations for vaccinating health0care personnel born before !"+-
routinel$ and during outbrea1s.
The term 2seasonal3 has been added to the in4uen5a footnote (##).
The hepatitis ' footnote (#") has language added to indicate that
unvaccinated persons ,ho anticipate close contact ,ith an international
adoptee should consider vaccination.
The hepatitis 6 footnote (#!7) has language added to include schedule
information for the 80dose hepatitis 6 vaccine.
The meningococcal vaccine footnote (#!!) clari.es ,hich vaccine
formulations are preferred for adults aged 9++ $ears and :+# $ears& and
,hich vaccine formulation can be used for revaccination. ;e, e<amples have
been added to demonstrate ,ho should and should not be considered for
revaccination.
The selected conditions for Haemophilus infuenza t$pe b (Hib) footnote
(#!8) clari.es ,hich high0ris1 persons ma$ receive ! dose of Hib vaccine.
The 4ecommended Adult Immunization Schedule has been a$$roved by the Advisory
Committee on Immunization Practices# the American Academy of 5amily Physicians# the
American Colle&e of Obstetricians and 6ynecolo&ists# and the American Colle&e of Physicians.
Suggested citation: Centers for 7isease Control and Prevention. 4ecommended adult
immunization schedule///8nited States# !%!. 99:4 !%!0;"(%).
5I684- %. 4ecommended adult immunization schedule# by vaccine and a&e &rou$ / 8nited
States# !%!
Alternative Text: The fi&ure above shows the recommended adult immunization schedule# by
vaccine and a&e &rou$ for the 8nited States in !%!.
5I684- . (accines that mi&ht be indicated for adults# based on medical and other indications /
8nited States# !%!
Alternative Text: The fi&ure above shows vaccines that mi&ht be indicated for adults# based on
medical and other indications in the 8nited States for !%!.
!. Tetanus& diphtheria& and acellular pertussis (Td=Tdap) vaccination
Tda$ should re$lace a sin&le dose of Td for adults a&ed %"//3* years who have not
received a dose of Tda$ $reviously.
Adults with uncertain or incom$lete history of $rimary vaccination series with tetanus
and di$htheria to<oid/containin& vaccines should be&in or com$lete a $rimary
vaccination series. A $rimary series for adults is = doses of tetanus and di$htheria to<oid/
containin& vaccines0 administer the first doses at least * wee>s a$art and the third dose
3//% months after the second0 Tda$ can substitute for any one of the doses of Td in the
=/dose $rimary series. The booster dose of tetanus and di$htheria to<oid/containin&
vaccine should be administered to adults who have com$leted a $rimary series and if the
last vaccination was received ?%! years $reviously. Tda$ or Td vaccine may be used# as
indicated.
If a woman is $re&nant and received the last Td vaccination ?%! years $reviously#
administer Td durin& the second or third trimester. If the woman received the last Td
vaccination @%! years $reviously# administer Tda$ durin& the immediate $ost$artum
$eriod. A dose of Tda$ is recommended for $ost$artum women# close contacts of infants
a&ed @% months# and all health/care $ersonnel with direct $atient contact if they have
not $reviously received Tda$. An interval as short as years from the last Td vaccination
is su&&ested0 shorter intervals can be used. Td may be deferred durin& $re&nancy and
Tda$ substituted in the immediate $ost$artum $eriod# or Tda$ can be administered
instead of Td to a $re&nant woman.
Consult the ACIP statement for recommendations for &ivin& Td as $ro$hyla<is in wound
mana&ement.
2. Human papillomavirus (HPV) vaccination
'P( vaccination is recommended at a&e %% or % years with catch/u$ vaccination at a&es
%= throu&h 3 years.
Ideally# vaccine should be administered before $otential e<$osure to 'P( throu&h se<ual
activity0 however# females who are se<ually active should still be vaccinated consistent
with a&e/based recommendations. Se<ually active females who have not been infected
with any of the four 'P( vaccine ty$es (ty$es 3# %%# %3# %1# all of which 'P(* $revents)
or any of the two 'P( vaccine ty$es (ty$es %3 and %1# both of which 'P( $revents)
receive the full benefit of the vaccination. (accination is less beneficial for females who
have already been infected with one or more of the 'P( vaccine ty$es. 'P(* or 'P(
can be administered to $ersons with a history of &enital warts# abnormal Pa$anicolaou
test# or $ositive 'P( 7AA test# because these conditions are not evidence of $rior
infection with all vaccine 'P( ty$es.
'P(* may be administered to males a&ed " throu&h 3 years to reduce their li>elihood of
ac)uirin& &enital warts. 'P(* would be most effective when administered before
e<$osure to 'P( throu&h se<ual contact.
A com$lete series for either 'P(* or 'P( consists of = doses. The second dose should
be administered %// months after the first dose0 the third dose should be administered 3
months after the first dose.
Althou&h 'P( vaccination is not s$ecifically recommended for $ersons with the medical
indications described in 5i&ure # B(accines that mi&ht be indicated for adults based on
medical and other indications#B it may be administered to these $ersons because the 'P(
vaccine is not a live/virus vaccine. 'owever# the immune res$onse and vaccine efficacy
mi&ht be less for $ersons with the medical indications described in 5i&ure than in
$ersons who do not have the medical indications described or who are
immunocom$etent. 'ealth/care $ersonnel are not at increased ris> because of
occu$ational e<$osure and should be vaccinated consistent with a&e/based
recommendations.
8. Varicella vaccination
All adults without evidence of immunity to varicella should receive doses of sin&le/
anti&en varicella vaccine if not $reviously vaccinated or the second dose if they have
received only % dose# unless they have a medical contraindication. S$ecial consideration
should be &iven to those who %) have close contact with $ersons at hi&h ris> for severe
disease (e.&.# health/care $ersonnel and family contacts of $ersons with
immunocom$romisin& conditions) or ) are at hi&h ris> for e<$osure or transmission
(e.&.# teachers0 child/care em$loyees0 residents and staff members of institutional settin&s#
includin& correctional institutions0 colle&e students0 military $ersonnel0 adolescents and
adults livin& in households with children0 non$re&nant women of childbearin& a&e0 and
international travelers).
-vidence of immunity to varicella in adults includes any of the followin&, %)
documentation of doses of varicella vaccine at least * wee>s a$art0 ) 8.S./born before
%"1! (althou&h for health/care $ersonnel and $re&nant women# birth before %"1! should
not be considered evidence of immunity)0 =) history of varicella based on dia&nosis or
verification of varicella by a health/care $rovider (for a $atient re$ortin& a history of or
havin& an aty$ical case# a mild case# or both# health/care $roviders should see> either an
e$idemiolo&ic lin> with a ty$ical varicella case or to a laboratory/confirmed case or
evidence of laboratory confirmation# if it was $erformed at the time of acute disease)0 *)
history of her$es zoster based on dia&nosis or verification of her$es zoster by a health/
care $rovider0 or ;) laboratory evidence of immunity or laboratory confirmation of
disease.
Pre&nant women should be assessed for evidence of varicella immunity. :omen who do
not have evidence of immunity should receive the first dose of varicella vaccine u$on
com$letion or termination of $re&nancy and before dischar&e from the health/care
facility. The second dose should be administered *//1 wee>s after the first dose.
. Herpes 5oster vaccination
A sin&le dose of zoster vaccine is recommended for adults a&ed ?3! years re&ardless of
whether they re$ort a $rior e$isode of her$es zoster. Persons with chronic medical
conditions may be vaccinated unless their condition constitutes a contraindication.
+. )easles& mumps& rubella ())*) vaccination
Adults born before %";2 &enerally are considered immune to measles and mum$s.
9easles com$onent, Adults born durin& or after %";2 should receive % or more doses of
994 vaccine unless they have %) a medical contraindication0 ) documentation of
vaccination with % or more doses of 994 vaccine0 =) laboratory evidence of immunity0
or *) documentation of $hysician/dia&nosed measles.
A second dose of 994 vaccine# administered * wee>s after the first dose# is
recommended for adults who %) have been recently e<$osed to measles or are in an
outbrea> settin&0 ) have been vaccinated $reviously with >illed measles vaccine0 =) have
been vaccinated with an un>nown ty$e of measles vaccine durin& %"3=//%"320 *) are
students in $ostsecondary educational institutions0 ;) wor> in a health/care facility0 or 3)
$lan to travel internationally.
9um$s com$onent, Adults born durin& or after %";2 should receive % dose of 994
vaccine unless they have %) a medical contraindication0 ) documentation of vaccination
with % or more doses of 994 vaccine0 =) laboratory evidence of immunity0 or *)
documentation of $hysician/dia&nosed mum$s.
A second dose of 994 vaccine# administered * wee>s after the first dose# is
recommended for adults who %) live in a community e<$eriencin& a mum$s outbrea> and
are in an affected a&e &rou$0 ) are students in $ostsecondary educational institutions0 =)
wor> in a health/care facility0 or *) $lan to travel internationally.
4ubella com$onent, % dose of 994 vaccine is recommended for women who do not
have documentation of rubella vaccination# or who lac> laboratory evidence of immunity.
5or women of childbearin& a&e# re&ardless of birth year# rubella immunity should be
determined# and women should be counseled re&ardin& con&enital rubella syndrome.
:omen who do not have evidence of immunity should receive 994 vaccine u$on
com$letion or termination of $re&nancy and before dischar&e from the health/care
facility.
'ealth/care $ersonnel born before %";2, 5or unvaccinated health/care $ersonnel born
before %";2 who lac> laboratory evidence of measles# mum$s# and.or rubella immunity
or laboratory confirmation of disease# health/care facilities should consider vaccinatin&
$ersonnel with doses of 994 vaccine at the a$$ro$riate interval (for measles and
mum$s) and % dose of 994 vaccine (for rubella)# res$ectively.
7urin& outbrea>s# health/care facilities should recommend that unvaccinated health/care
$ersonnel born before %";2# who lac> laboratory evidence of measles# mum$s# and.or
rubella immunity or laboratory confirmation of disease# receive doses of 994 vaccine
durin& an outbrea> of measles or mum$s# and % dose durin& an outbrea> of rubella.
Com$lete information about evidence of immunity is available at
htt$,..www.cdc.&ov.vaccines.recs.$rovisional.default.htm.
#. >easonal in4uen5a vaccination
(accinate all $ersons a&ed ?;! years and any youn&er $ersons who would li>e to
decrease their ris> for influenza. (accinate $ersons a&ed %" throu&h *" years with any of
the followin& indications.
9edical, Chronic disorders of the cardiovascular or $ulmonary systems# includin&
asthma0 chronic metabolic diseases (includin& diabetes mellitus)0 renal or he$atic
dysfunction# hemo&lobino$athies# or immunocom$romisin& conditions (includin&
immunocom$romisin& conditions caused by medications or 'I()0 co&nitive# neurolo&ic#
or neuromuscular disorders0 and $re&nancy durin& the influenza season. Ao data e<ist on
the ris> for severe or com$licated influenza disease amon& $ersons with as$lenia0
however# influenza is a ris> factor for secondary bacterial infections that can cause severe
disease amon& $ersons with as$lenia.
Occu$ational, All health/care $ersonnel# includin& those em$loyed by lon&/term care and
assisted/livin& facilities# and care&ivers of children a&ed @; years.
Other, 4esidents of nursin& homes and other lon&/term care and assisted/livin& facilities0
$ersons li>ely to transmit influenza to $ersons at hi&h ris> (e.&.# in/home household
contacts and care&ivers of children a&ed @; years# $ersons a&ed ?;! years# and $ersons of
all a&es with hi&h/ris> conditions).
'ealthy# non$re&nant adults a&ed @;! years without hi&h/ris> medical conditions who are
not contacts of severely immunocom$romised $ersons in s$ecial/care units may receive
either intranasally administered live# attenuated influenza vaccine (5lu9ist) or
inactivated vaccine. Other $ersons should receive the inactivated vaccine.
-. Pneumococcal pol$saccharide (PP>V) vaccination
(accinate all $ersons with the followin& indications.
9edical, Chronic lun& disease (includin& asthma)0 chronic cardiovascular diseases0
diabetes mellitus0 chronic liver diseases# cirrhosis0 chronic alcoholism0 functional or
anatomic as$lenia (e.&.# sic>le cell disease or s$lenectomy Cif elective s$letnectomy is
$lanned# vaccinate at least wee>s before sur&eryD)0 immunocom$romisin& conditions
(includin& chronic renal failure or ne$hrotic syndrome)0 and cochlear im$lants and
cerebros$inal fluid lea>s. (accinate as close to 'I( dia&nosis as $ossible.
Other, 4esidents of nursin& homes or lon&/term care facilities and $ersons who smo>e
ci&arettes. 4outine use of PPS( is not recommended for American Indians.Alas>a
Aatives or $ersons a&ed @3; years unless they have underlyin& medical conditions that
are PPS( indications. 'owever# $ublic health authorities may consider recommendin&
PPS( for American Indians.Alas>a Aatives and $ersons a&ed ;! throu&h 3* years who
are livin& in areas where the ris> for invasive $neumococcal disease is increased.
?. *evaccination ,ith PP>V
One/time revaccination after ; years is recommended for $ersons with chronic renal
failure or ne$hrotic syndrome0 functional or anatomic as$lenia (e.&.# sic>le cell disease or
s$lenectomy)0 and for $ersons with immunocom$romisin& conditions. 5or $ersons a&ed
?3; years# one/time revaccination is recommended if they were vaccinated ?; years
$reviously and were a&ed @3; years at the time of $rimary vaccination.
". Hepatitis ' vaccination
(accinate $ersons with any of the followin& indications and any $erson see>in&
$rotection from he$atitis A virus ('A() infection.
+ehavioral, 9en who have se< with men and $ersons who use inEection dru&s.
Occu$ational, Persons wor>in& with 'A(/infected $rimates or with 'A( in a research
laboratory settin&.
9edical, Persons with chronic liver disease and $ersons who receive clottin& factor
concentrates.
Other, Persons travelin& to or wor>in& in countries that have hi&h or intermediate
endemicity of he$atitis A (a list of countries is available at
htt$,..wwwn.cdc.&ov.travel.contentdiseases.as$<).
8nvaccinated $ersons who antici$ate close $ersonal contact (e.&.# household contact or
re&ular babysittin&) with an international ado$tee from a country of hi&h or intermediate
endemicity durin& the first 3! days after arrival of the ado$tee in the 8nited States should
consider vaccination. The first dose of the /dose he$atitis A vaccine series should be
administered as soon as ado$tion is $lanned# ideally ? wee>s before the arrival of the
ado$tee.
Sin&le/anti&en vaccine formulations should be administered in a /dose schedule at either
! and 3//% months ('avri<)# or ! and 3//%1 months ((a)ta). If the combined he$atitis A
and he$atitis + vaccine (Twinri<) is used# administer = doses at !# %# and 3 months0
alternatively# a */dose schedule# administered on days !# 2# and %//=! followed by a
booster dose at month % may be used.
!7.Hepatitis 6 vaccination
(accinate $ersons with any of the followin& indications and any $erson see>in&
$rotection from he$atitis + virus ('+() infection.
+ehavioral, Se<ually active $ersons who are not in a lon&/term# mutually mono&amous
relationshi$ (e.&.# $ersons with more than one se< $artner durin& the $revious 3 months)0
$ersons see>in& evaluation or treatment for a se<ually transmitted disease (ST7)0 current
or recent inEection/dru& users0 and men who have se< with men.
Occu$ational, 'ealth/care $ersonnel and $ublic/safety wor>ers who are e<$osed to blood
or other $otentially infectious body fluids.
9edical, Persons with end/sta&e renal disease# includin& $atients receivin& hemodialysis0
$ersons with 'I( infection0 and $ersons with chronic liver disease.
Other, 'ousehold contacts and se< $artners of $ersons with chronic '+( infection0
clients and staff members of institutions for $ersons with develo$mental disabilities0 and
international travelers to countries with hi&h or intermediate $revalence of chronic '+(
infection (a list of countries is available at
htt$,.. wwwn.cdc.&ov.travel.contentdiseases.as$<).
'e$atitis + vaccination is recommended for all adults in the followin& settin&s, ST7
treatment facilities0 'I( testin& and treatment facilities0 facilities $rovidin& dru&/abuse
treatment and $revention services0 health/care settin&s tar&etin& services to inEection/dru&
users or men who have se< with men0 correctional facilities0 end/sta&e renal disease
$ro&rams and facilities for chronic hemodialysis $atients0 and institutions and
nonresidential day/care facilities for $ersons with develo$mental disabilities.
Administer or com$lete a =/dose series of he$atitis + vaccine to those $ersons not
$reviously vaccinated. The second dose should be administered % month after the first
dose0 the third dose should be administered at least months after the second dose (and at
least * months after the first dose). If the combined he$atitis A and he$atitis + vaccine
(Twinri<) is used# administer = doses at !# %# and 3 months0 alternatively# a */dose
schedule# administered on days !# 2# and %//=! followed by a booster dose at month %
may be used.
Adult $atients receivin& hemodialysis or with other immunocom$romisin& conditions
should receive % dose of *! F&.mG (4ecombiva< '+) administered on a =/dose schedule
or doses of ! F&.mG (-n&eri</+) administered simultaneously on a */dose schedule at
!# %# # and 3 months.
!!.)eningococcal vaccination
9enin&ococcal vaccine should be administered to $ersons with the followin& indications.
9edical, Adults with anatomic or functional as$lenia# or $ersistent com$lement
com$onent deficiencies.
Other, 5irst/year colle&e students livin& in dormitories0 microbiolo&ists routinely e<$osed
to isolates of Aeisseria menin&itidis0 military recruits0 and $ersons who travel to or live in
countries in which menin&ococcal disease is hy$erendemic or e$idemic (e.&.# the
Bmenin&itis beltB of sub/Saharan Africa durin& the dry season C7ecember throu&h HuneD)#
$articularly if their contact with local $o$ulations will be $rolon&ed. (accination is
re)uired by the &overnment of Saudi Arabia for all travelers to 9ecca durin& the annual
'aEE.
9enin&ococcal conEu&ate vaccine (9C(*) is $referred for adults with any of the
$recedin& indications who are a&ed I;; years0 menin&ococcal $olysaccharide vaccine
(9PS(*) is $referred for adults a&ed ?;3 years. 4evaccination with 9C(* after ; years
is recommended for adults $reviously vaccinated with 9C(* or 9PS(* who remain at
increased ris> for infection (e.&.# adults with anatomic or functional as$lenia). Persons
whose only ris> factor is livin& in on/cam$us housin& are not recommended to receive an
additional dose.
!2.%mmunocompromising conditions
Inactivated vaccines &enerally are acce$table (e.&.# $neumococcal# menin&ococcal#
influenza Cinactivated influenza vaccineD) and live vaccines &enerally are avoided in
$ersons with immune deficiencies or immunocom$romisin& conditions. Information on
s$ecific conditions is available at htt$,.. www.cdc.&ov.vaccines.$ubs.aci$/list.htm.
!8.>elected conditions for ,hich Haemophilus in4uen5ae t$pe b (Hib) vaccine
ma$ be used
'ib vaccine &enerally is not recommended for $ersons a&ed ?; years. Ao efficacy data
are available on which to base a recommendation concernin& use of 'ib vaccine for older
children and adults. 'owever# studies su&&est &ood immuno&enicity in $atients who have
sic>le cell disease# leu>emia# or 'I( infection or who have had a s$lenectomy.
Administerin& % dose of 'ib vaccine to these hi&h/ris> $ersons who have not $reviously
received 'ib vaccine is not contraindicated.
These schedules indicate the recommended a&e &rou$s and medical indications for which
administration of currently licensed vaccines is commonly indicated for adults a&ed ?%" years# as
of Hanuary %# !!". Gicensed combination vaccines may be used whenever any com$onents of the
combination are indicated and when the vaccineJs other com$onents are not contraindicated. 5or
detailed recommendations on all vaccines# includin& those that are used $rimarily for travelers or
are issued durin& the year# consult the manufacturersJ $ac>a&e inserts and the com$lete
statements from the Advisory Committee on Immunization Practices (ACIP)
(htt$,..www.cdc.&ov.vaccines.$ubs.aci$/list.htm).
4e$ort all clinically si&nificant $ostvaccination reactions to the (accine Adverse -vent 4e$ortin&
System ((A-4S). 4e$ortin& forms and instructions on filin& a (A-4S re$ort are available at
htt$,..www.vaers.hhs.&ov or by tele$hone# 1!!/1/2"32.
Information on how to file a (accine InEury Com$ensation Pro&ram claim is available at
htt$,..www.hrsa.&ov.vaccinecom$ensation or by tele$hone# 1!!/==1/=1. To file a claim for
vaccine inEury# contact the 8.S. Court of 5ederal Claims# 2%2 9adison Place# A.:.# :ashin&ton#
7.C. !!!;0 tele$hone# !/=;2/3*!!.
Additional information about the vaccines in this schedule# e<tent of available data# and
contraindications for vaccination is available at htt$,..www.cdc.&ov.vaccines or from the C7C/
IA5O Contact Center at 1!!/C7C/IA5O (1!!/=/*3=3) in -n&lish and S$anish# * hours a day#
2 days a wee>.
8se of trade names and commercial sources is for identification only and does not im$ly
endorsement by the 8.S. 7e$artment of 'ealth and 'uman Services.
The recommendations in this schedule were a$$roved by ACIP# the American Academy of 5amily
Physicians# the American Colle&e of Obstetricians and 6ynecolo&ists# and the American Colle&e
of Physicians.
7e$artment of 'ealth and 'uman Services K Centers for 7isease Control and Prevention
8se of trade names and commercial sources is for identification only and does not im$ly endorsement by the 8.S.
7e$artment of 'ealth and 'uman Services.
4eferences to non/C7C sites on the Internet are $rovided as a service to MMWR readers and do not constitute or
im$ly endorsement of these or&anizations or their $ro&rams by C7C or the 8.S. 7e$artment of 'ealth and 'uman
Services. C7C is not res$onsible for the content of $a&es found at these sites. 84G addresses listed in MMWR were
current as of the date of $ublication.
All MMWR 'T9G versions of articles are electronic conversions from ty$eset documents. This conversion mi&ht
result in character translation or format errors in the 'T9G version. 8sers are referred to the electronic P75 version
(htt$,..www.cdc.&ov.mmwr) and.or the ori&inal MMWR $a$er co$y for $rintable versions of official te<t# fi&ures#
and tables. An ori&inal $a$er co$y of this issue can be obtained from the Su$erintendent of 7ocuments# 8.S.
6overnment Printin& Office (6PO)# :ashin&ton# 7C !*!/"=2%0 tele$hone, (!) ;%/%1!!. Contact 6PO for
current $rices.
Immunisation Schedule
Age Where Vaccine
Birth os!ital " #linic B#$
2 %onths $& ' in 1 ( &#V
) %onths $& ' in 1 ( %en #
' %onths $& ' in 1 ( %en # ( &#V
12 %onths $& %%* ( &#V
1+ %onths $& %en # ( i,
)-. /ears $& " School ) in 1 ( %%*
1st /ear
Secondar0 School
School &V ($irls 1nl0)
'th /ear
Secondar0 School
School &V ($irls 1nl0)
1st /ear
Secondar0 School
School Tda!
Senior In2ants - 1st /ear
Secondar0 School
School %%*
7ownload the BLour childMs immunisation / A &uide for $arentsB boo>let for more information
about the $rimary childhood $ro&ramme. (+irth / %= months of a&e)
(&lease note - the schedule for the first %= months of life shown in the table above was
introduced in Se$tember !!1 for all children born on or after %st Huly !!1. In Se$tember !%!
the 'P( vaccination $ro&ramme was introduced3 The Tda$ $ro&ramme was introduced in
Se$tember !%%.)
A,,reviations used in the ta,le a,ove are ex!lained ,elo4
B#$ 5 Bacille #almette-$uerin (TB - Tu,erculosis vaccine)
' in 1 5 6i!htheria7 haemo!hilus in2luen8ae B (i,)7 he!atitis B7 !ertussis (Whoo!ing #ough)7 !olio and
tetanus
&#V 5 &neumococcal vaccine
%en # 5 %eningococcal #
%%* 5 %easles7 mum!s7 ru,ella
i, 5 aemo!hilus in2luen8ae B
) in 1 5 6i!htheria7 tetanus7 !olio7 !ertussis (4hoo!ing cough)
&V 5 uman !a!illomavirus
Tda! 5 Tetanus7 lo4 dose di!htheria7 accelular !ertussis

The Aational Immunisation Office have $roduced su$$ort materials to e<$lain the diseases listed
in the table above# these are available for download below. Lou need to read these materials
carefully before &oin& for vaccination# if you have any )uestions you should s$ea> with your
childs 6P or Practice Aurse.
In2ormation 2or !arents 4ho have children u! to the age o2 1+ months is availa,le ,elo4
In Se$tember !!1 a new immunisation schedule was introduced for all children born on or after
%st Huly !!1. In A$ril !%% the information materials for $arents were u$dated followin&
consultation with $arents.
Lour childs immunisations boo>let is available from your $ublic health nurse or 6P. It is also
available for download here. This boo>let &ives you more information about immunisation
and should also answer any other )uestions you may have. If you still have any )ueries $lease
s$ea> to your childs 6P or Practice Aurse.
This boo>let contains a $oc>et in the bac> of the boo> that contains a frid&e ma&net and an
immunisation $ass$ort.
The ma&net can be downloaded from here / it contains a co$y of the immunisation
schedule for your child.
The $ass$ort can be downloaded from here / this is a useful boo>let as it allows you to
>ee$ a record of all of the vaccinations you child has received to date and it also acts as a
reminder of the vaccines your child needs in the future. Please >ee$ this boo>let safe as
you may be as>ed to $rovide information contained in it when your child &oes to creche#
school# =rd level education or em$loyment.
Immunisation $osters are also available to download below
Poster % / contains the schedule
Poster / reminds you ; visits are needed to fully vaccinate your baby
In Ireland# all the recommended immunisations listed in the $rimary childhood immunisation
schedule are free.
4-9-9+-4 your child needs 5I(- visits to your 6P to com$lete their course of vaccines and
be fully $rotected a&ainst serious diseases.

In2ormation 2or !arents 4ho have children aged ) 0ears to 1) 0ears o2 age is availa,le
,elo4
Children need to &et booster doses of some vaccines in school to $rotect them a&ainst diseases.
:hen your child is a&ed * to ; years# they will be offered two vaccines,
the * in % booster to $rotect a&ainst di$htheria# $ertussis (whoo$in& cou&h)# $olio and
tetanus0 and
a second dose of the 994 vaccine to $rotect a&ainst measles# mum$s and rubella.
These vaccines are usually &iven by a 'S- doctor or nurse in school or in some areas by your
6P. Information is available to download here.
:hen your child is in %st year of secondary school# they will &et a tetanus# low/dose di$htheria
and accelular $ertussis booster vaccine. This vaccine is &iven by a 'S- doctor or nurse in
school. Information about the Tda$ vaccine is available to download here.
:hen your dau&hter is in first year of second level school# (about % years of a&e) she will &et
the 'P( ('uman Pa$illomavirus) vaccine# to $rotect a&ainst cervical cancer. Three doses of this
vaccine will be &iven over 3/% months. This vaccine is &iven by a 'S- doctor or nurse in
school. Clic> here to access information about the 'P( $ro&ramme.
In the !%/!%= school year 'P( vaccine will also be offered to 3th year &irls in secondary
school (about %1 years of a&e). Three doses of this vaccine will be &iven over 3/% months. This
vaccine is &iven by a 'S- doctor or nurse in school. Clic> here to access information about the
'P( $ro&ramme.
This year (!%=/!%*) a dose of 994 vaccine is bein& offered to students in Senior Infants / 3th
Class of $rimary school and %st year students in Second Gevel Schools. Clic> here to access
information about 994.
:hen these vaccines are &iven in school the 'S- will let you >now the date of immunisations. If
your child misses that immunisation in school# the 'S- will arran&e for your child to be
vaccinated at a clinic.

This section 4as last u!dated 1+th 9ovem,er 2:1+